Search results
Results from the WOW.Com Content Network
Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ...
On Johnson & Johnson's earnings call earlier this month, management provided an update on the talc lawsuits. Chief Financial Officer Joseph Wolk says that claimants will be able to vote on the ...
Johnson & Johnson proposes $8.9bn settlement fund for talcum powder cancer lawsuits ... 2023 at 10:05 PM. ... The proposed settlement would see the company pay out $8.9bn over 25 years through a ...
For the fiscal year 2023, Johnson & Johnson reported earnings of $35.15 billion, with an annual revenue of $85.16 billion, an increase of 10.57% over the previous fiscal cycle. Johnson & Johnson's shares traded at over $160 per share, and its market capitalization was valued at over $386.7 billion in July 2024. [126]
A plaintiffs' lawyer who represents 11,434 of approximately J&J's roughly 100,000 talc claimants said the company's figure is inflated, and its latest bankruptcy petition is "fraught with problems."
NEW YORK (Reuters) -A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a federal bankruptcy court in ...
Using AOL Calendar lets you keep track of your schedule with just a few clicks of a mouse. While accessing your calendar online gives you instant access to appointments and events, sometimes a physical copy of your calendar is needed. To print your calendar, just use the print functionality built into your browser.
JPMorgan Chase analysts in a separate note after J&J earnings last week said the talc settlement progress was "one of the most important drivers" of the company's stock in 2023.